Why Is Intel Struggling Against AMD?
Due to its disappointing reports, so-so management, and lack of…
Sell
33
MRNA Quote, Financials, Valuation and Earnings
Last price:
$26.51
Seasonality move
:
22.93%
Day range:
$26.45 - $27.88
52-week range:
$23.15 - $170.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.12x
P/B ratio:
0.91x
Volume:
5.5M
Avg. volume:
9.1M
1-year change:
-75.4%
Market cap:
$10B
Revenue:
$3.2B
EPS (TTM):
-$9.28
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $274M | $17.7B | $18.9B | $6.8B | $3.2B | |
| Revenue Growth (YoY) | 470.83% | 6372.99% | 6.42% | -64.22% | -52.64% | |
| Cost of Revenues | $8M | $2.6B | $5.4B | $4.7B | $1.5B | |
| Gross Profit | $266M | $15.1B | $13.5B | $2.1B | $1.7B | |
| Gross Profit Margin | 97.08% | 85.25% | 71.31% | 30.52% | 54.24% | |
| R&D Expenses | $1.4B | $2B | $3.3B | $4.8B | $4.5B | |
| Selling, General & Admin | $188M | $567M | $1.1B | $1.5B | $1.2B | |
| Other Inc / (Exp) | -$6M | -$29M | -$45M | -$86M | -$63M | |
| Operating Expenses | $1B | $1.8B | $4B | $6.3B | $5.7B | |
| Operating Income | -$763M | $13.3B | $9.4B | -$4.2B | -$3.9B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$744M | $13.3B | $9.6B | -$3.9B | -$3.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3M | $1.1B | $1.2B | $772M | -$46M | |
| Net Income to Company | -$747M | $12.2B | $8.4B | -$4.7B | -$3.6B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$747M | $12.2B | $8.4B | -$4.7B | -$3.6B | |
| Basic EPS (Cont. Ops) | -$1.96 | $30.31 | $21.26 | -$12.33 | -$9.28 | |
| Diluted EPS (Cont. Ops) | -$1.96 | $28.29 | $20.12 | -$12.33 | -$9.28 | |
| Weighted Average Basic Share | $381M | $403M | $394M | $382M | $384M | |
| Weighted Average Diluted Share | $381M | $431M | $416M | $382M | $384M | |
| EBITDA | -$732M | $13.5B | $9.8B | -$3.3B | -$3.4B | |
| EBIT | -$763M | $13.3B | $9.4B | -$3.9B | -$3.6B | |
| Revenue (Reported) | $274M | $17.7B | $18.9B | $6.8B | $3.2B | |
| Operating Income (Reported) | -$763M | $13.3B | $9.4B | -$4.2B | -$3.9B | |
| Operating Income (Adjusted) | -$763M | $13.3B | $9.4B | -$3.9B | -$3.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $229M | $6.9B | $5.1B | $2.8B | $956M | |
| Revenue Growth (YoY) | 2077.43% | 2934.5% | -25.9% | -45.37% | -66.02% | |
| Cost of Revenues | $8M | $952M | $1.9B | $929M | $739M | |
| Gross Profit | $221M | $6B | $3.2B | $1.9B | $217M | |
| Gross Profit Margin | 96.51% | 86.3% | 62.75% | 66.98% | 22.7% | |
| R&D Expenses | $759M | $648M | $1.2B | $1.4B | $1.1B | |
| Selling, General & Admin | $79M | $201M | $375M | $470M | $351M | |
| Other Inc / (Exp) | -- | -$19M | -$31M | -$33M | -$23M | |
| Operating Expenses | $496M | $587M | $1.7B | $1.9B | $1.5B | |
| Operating Income | -$275M | $5.4B | $1.6B | $6M | -$1.2B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$271M | $5.4B | $1.7B | $70M | -$1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2M | $542M | $190M | -$147M | -$64M | |
| Net Income to Company | -$273M | $4.9B | $1.5B | $217M | -$1.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$273M | $4.9B | $1.5B | $217M | -$1.1B | |
| Basic EPS (Cont. Ops) | -$0.69 | $12.03 | $3.81 | $0.57 | -$2.91 | |
| Diluted EPS (Cont. Ops) | -$0.69 | $11.29 | $3.61 | $0.55 | -$2.91 | |
| Weighted Average Basic Share | $396M | $406M | $388M | $382M | $387M | |
| Weighted Average Diluted Share | $396M | $431M | $407M | $382M | $387M | |
| EBITDA | -$289M | $5.5B | $1.6B | $278M | -$1.1B | |
| EBIT | -$296M | $5.4B | $1.5B | $76M | -$1.2B | |
| Revenue (Reported) | $229M | $6.9B | $5.1B | $2.8B | $956M | |
| Operating Income (Reported) | -$275M | $5.4B | $1.6B | $6M | -$1.2B | |
| Operating Income (Adjusted) | -$296M | $5.4B | $1.5B | $76M | -$1.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $274M | $17.7B | $18.9B | $6.8B | $3.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $2.6B | $5.4B | $4.7B | $1.5B | |
| Gross Profit | $266M | $15.1B | $13.5B | $2.1B | $1.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $1.4B | $2B | $3.3B | $4.8B | $4.5B | |
| Selling, General & Admin | $188M | $567M | $1.1B | $1.5B | $1.2B | |
| Other Inc / (Exp) | -- | -$29M | -$45M | -$86M | -$63M | |
| Operating Expenses | $1B | $1.8B | $4B | $6.3B | $5.7B | |
| Operating Income | -$763M | $13.3B | $9.4B | -$4.2B | -$3.9B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$744M | $13.3B | $9.6B | -$3.9B | -$3.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3M | $1.1B | $1.2B | $772M | -$46M | |
| Net Income to Company | -$747M | $12.2B | $8.4B | -$4.7B | -$3.6B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$747M | $12.2B | $8.4B | -$4.7B | -$3.6B | |
| Basic EPS (Cont. Ops) | -$1.94 | $30.28 | $21.12 | -$12.38 | -$9.28 | |
| Diluted EPS (Cont. Ops) | -$1.94 | $28.29 | $19.96 | -$12.41 | -$9.28 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$732M | $13.5B | $9.8B | -$3.3B | -$3.4B | |
| EBIT | -$763M | $13.3B | $9.4B | -$3.9B | -$3.6B | |
| Revenue (Reported) | $274M | $17.7B | $18.9B | $6.8B | $3.2B | |
| Operating Income (Reported) | -$763M | $13.3B | $9.4B | -$4.2B | -$3.9B | |
| Operating Income (Adjusted) | -$763M | $13.3B | $9.4B | -$3.9B | -$3.6B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.7B | $18.9B | $6.8B | $3.2B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.6B | $5.4B | $4.7B | $1.5B | -- | |
| Gross Profit | $15.1B | $13.5B | $2.1B | $1.7B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2B | $3.3B | $4.8B | $4.5B | -- | |
| Selling, General & Admin | $567M | $1.1B | $1.5B | $1.2B | -- | |
| Other Inc / (Exp) | -$29M | -$45M | -$86M | -$63M | -- | |
| Operating Expenses | $1.8B | $4B | $6.3B | $5.7B | -- | |
| Operating Income | $13.3B | $9.4B | -$4.2B | -$3.9B | -- | |
| Net Interest Expenses | $2M | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $13.3B | $9.6B | -$3.9B | -$3.6B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1B | $1.2B | $772M | -$46M | -- | |
| Net Income to Company | $12.2B | $8.4B | -$4.7B | -$3.6B | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $12.2B | $8.4B | -$4.7B | -$3.6B | -- | |
| Basic EPS (Cont. Ops) | $30.28 | $21.12 | -$12.38 | -$9.28 | -- | |
| Diluted EPS (Cont. Ops) | $28.29 | $19.96 | -$12.41 | -$9.28 | -- | |
| Weighted Average Basic Share | $1.6B | $1.6B | $1.5B | $1.5B | -- | |
| Weighted Average Diluted Share | $1.7B | $1.7B | $1.5B | $1.6B | -- | |
| EBITDA | $13.5B | $9.8B | -$3.3B | -$3.4B | -- | |
| EBIT | $13.3B | $9.4B | -$3.9B | -$3.6B | -- | |
| Revenue (Reported) | $17.7B | $18.9B | $6.8B | $3.2B | -- | |
| Operating Income (Reported) | $13.3B | $9.4B | -$4.2B | -$3.9B | -- | |
| Operating Income (Adjusted) | $13.3B | $9.4B | -$3.9B | -$3.6B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.6B | $6.8B | $3.2B | $2.9B | $1.9B | |
| Short Term Investments | $2B | $3.9B | $6.7B | $5.7B | $5.1B | |
| Accounts Receivable, Net | $1.4B | $3.2B | $1.4B | $892M | $358M | |
| Inventory | $47M | $1.4B | $949M | $202M | $117M | |
| Prepaid Expenses | $224M | $554M | $851M | $350M | $307M | |
| Other Current Assets | $11M | $26M | $44M | $88M | $58M | |
| Total Current Assets | $6.3B | $16.1B | $13.4B | $10.3B | $8.1B | |
| Property Plant And Equipment | $387M | $1.4B | $2.1B | $2.7B | $3B | |
| Long-Term Investments | $639M | $6.8B | $8.4B | $4.7B | $2.5B | |
| Goodwill | -- | -- | -- | $52M | $52M | |
| Other Intangibles | -- | -- | -- | $44M | $40M | |
| Other Long-Term Assets | $13M | $46M | $946M | $181M | $171M | |
| Total Assets | $7.3B | $24.7B | $25.9B | $18.4B | $14.1B | |
| Accounts Payable | $18M | $302M | $487M | $520M | $405M | |
| Accrued Expenses | $375M | $1.3B | $1.9B | $997M | $745M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $30M | $211M | $196M | $25M | $37M | |
| Other Current Liabilities | $4M | $14M | $53M | $41M | $181M | |
| Total Current Liabilities | $4.4B | $9.1B | $4.9B | $3B | $2.2B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.8B | $10.5B | $6.7B | $4.6B | $3.2B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $3M | -$24M | -$370M | -$123M | -$10M | |
| Common Equity | $2.6B | $14.1B | $19.1B | $13.9B | $10.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2.6B | $14.1B | $19.1B | $13.9B | $10.9B | |
| Total Liabilities and Equity | $7.3B | $24.7B | $25.9B | $18.4B | $14.1B | |
| Cash and Short Terms | $4.6B | $10.7B | $9.9B | $8.6B | $7B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.6B | $6.8B | $3.2B | $2.9B | $1.9B | |
| Short Term Investments | $2B | $3.9B | $6.7B | $5.7B | $5.1B | |
| Accounts Receivable, Net | $1.4B | $3.2B | $1.4B | $892M | $358M | |
| Inventory | $47M | $1.4B | $949M | $202M | $117M | |
| Prepaid Expenses | $224M | $554M | $851M | $350M | $307M | |
| Other Current Assets | $11M | $26M | $44M | $88M | $58M | |
| Total Current Assets | $6.3B | $16.1B | $13.4B | $10.3B | $8.1B | |
| Property Plant And Equipment | $387M | $1.4B | $2.1B | $2.7B | $3B | |
| Long-Term Investments | $639M | $6.8B | $8.4B | $4.7B | $2.5B | |
| Goodwill | -- | -- | -- | $52M | $52M | |
| Other Intangibles | -- | -- | -- | $44M | $40M | |
| Other Long-Term Assets | $13M | $46M | $946M | $181M | $171M | |
| Total Assets | $7.3B | $24.7B | $25.9B | $18.4B | $14.1B | |
| Accounts Payable | $18M | $302M | $487M | $520M | $405M | |
| Accrued Expenses | $375M | $1.3B | $1.9B | $997M | $745M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $30M | $211M | $196M | $25M | $37M | |
| Other Current Liabilities | $4M | $14M | $53M | $41M | $181M | |
| Total Current Liabilities | $4.4B | $9.1B | $4.9B | $3B | $2.2B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.8B | $10.5B | $6.7B | $4.6B | $3.2B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $3M | -$24M | -$370M | -$123M | -$10M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2.6B | $14.1B | $19.1B | $13.9B | $10.9B | |
| Total Liabilities and Equity | $7.3B | $24.7B | $25.9B | $18.4B | $14.1B | |
| Cash and Short Terms | $4.6B | $10.7B | $9.9B | $8.6B | $7B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$747M | $12.2B | $8.4B | -$4.7B | -$3.6B | |
| Depreciation & Amoritzation | $31M | $232M | $348M | $621M | $189M | |
| Stock-Based Compensation | $93M | $142M | $226M | $305M | $429M | |
| Change in Accounts Receivable | -$1.4B | -$1.8B | $1.8B | $493M | $534M | |
| Change in Inventories | -$47M | -$1.4B | $492M | $747M | $83M | |
| Cash From Operations | $2B | $13.6B | $5B | -$3.1B | -$3B | |
| Capital Expenditures | $68M | $284M | $400M | $707M | $1.1B | |
| Cash Acquisitions | -- | -- | -- | -$85M | -- | |
| Cash From Investing | -$1.7B | -$8.5B | -$5.2B | $4.2B | $1.9B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$857M | -$3.3B | -$1.2B | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $2B | -$873M | -$3.4B | -$1.4B | $56M | |
| Beginning Cash (CF) | $248M | $2.6B | $6.9B | $3.2B | $2.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.4B | $4.2B | -$3.6B | -$289M | -$999M | |
| Ending Cash (CF) | $2.6B | $6.9B | $3.2B | $2.9B | $1.9B | |
| Levered Free Cash Flow | $2B | $13.3B | $4.6B | -$3.8B | -$4.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$273M | $4.9B | $1.5B | $217M | -$1.1B | |
| Depreciation & Amoritzation | $7M | $78M | $80M | $202M | $60M | |
| Stock-Based Compensation | $26M | $37M | $62M | $79M | $104M | |
| Change in Accounts Receivable | -$1.2B | -$33M | $1.3B | $974M | $1.2B | |
| Change in Inventories | -$47M | -$476M | $1.1B | $285M | $291M | |
| Cash From Operations | $1.3B | $3.3B | $1.7B | $622M | $825M | |
| Capital Expenditures | $24M | $120M | $92M | $220M | $522M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$190M | -$1.1B | -$1B | -$538M | -$539M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$857M | -$402M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $44M | -$873M | -$438M | -$109M | -$3M | |
| Beginning Cash (CF) | $1.5B | $5.6B | $3B | $3B | $1.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.1B | $1.3B | $176M | -$25M | $282M | |
| Ending Cash (CF) | $2.6B | $6.9B | $3.2B | $2.9B | $1.9B | |
| Levered Free Cash Flow | $1.2B | $3.2B | $1.6B | $402M | $303M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$747M | $12.2B | $8.4B | -$4.7B | -$3.6B | |
| Depreciation & Amoritzation | $31M | $232M | $348M | $621M | $189M | |
| Stock-Based Compensation | $93M | $142M | $226M | $305M | $429M | |
| Change in Accounts Receivable | -$1.4B | -$1.8B | $1.8B | $493M | $534M | |
| Change in Inventories | -$47M | -$1.4B | $492M | $747M | $83M | |
| Cash From Operations | $2B | $13.6B | $5B | -$3.1B | -$3B | |
| Capital Expenditures | $68M | $284M | $400M | $707M | $1.1B | |
| Cash Acquisitions | -- | -- | -- | -$85M | -- | |
| Cash From Investing | -$1.7B | -$8.5B | -$5.2B | $4.2B | $1.9B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$857M | -$3.3B | -$1.2B | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $2B | -$873M | -$3.4B | -$1.4B | $56M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.4B | $4.2B | -$3.6B | -$289M | -$999M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2B | $13.3B | $4.6B | -$3.8B | -$4.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $12.2B | $8.4B | -$4.7B | -$3.6B | -- | |
| Depreciation & Amoritzation | $232M | $348M | $621M | $189M | -- | |
| Stock-Based Compensation | $142M | $226M | $305M | $429M | -- | |
| Change in Accounts Receivable | -$1.8B | $1.8B | $493M | $534M | -- | |
| Change in Inventories | -$1.4B | $492M | $747M | $83M | -- | |
| Cash From Operations | $13.6B | $5B | -$3.1B | -$3B | -- | |
| Capital Expenditures | $284M | $400M | $707M | $1.1B | -- | |
| Cash Acquisitions | -- | -- | -$85M | -- | -- | |
| Cash From Investing | -$8.5B | -$5.2B | $4.2B | $1.9B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$857M | -$3.3B | -$1.2B | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$873M | -$3.4B | -$1.4B | $56M | -- | |
| Beginning Cash (CF) | $19.3B | $17.8B | $13.5B | $9.1B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.2B | -$3.6B | -$289M | -$999M | -- | |
| Ending Cash (CF) | $23.5B | $14.2B | $13.2B | $8.1B | -- | |
| Levered Free Cash Flow | $13.3B | $4.6B | -$3.8B | -$4.1B | -- | |
Get MRNA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MRNA
Sector
P/E ratio
--
23.29x
PEG ratio
--
0.00x
P/B ratio
0.91x
1.56x
Price / LTM sales
3.12x
1.61x
Growth Metrics
MRNA
Sector
Revenue growth
-66.02%
6.38%
Earnings growth
--
8.33%
Revenue (5-year growth)
131.61%
8.19%
Earnings forecast
-$3.10
-$0.20
Profitability
MRNA
Sector
Profitability FY 2024
$1.7B
$54.7M
Return on invested capital
-29.09%
-14.83%
Return on assets
-22.04%
-12.04%
Return on equity
-29.09%
-17.27%
Earnings Date
Last Earnings Date
Feb
14
Next Earnings Date
May
1
Estimated Next Earnings Date
May
16
Balance Sheet
MRNA
Sector
Total cash
$7B
$40.4M
Short term investments
$5.1B
$36.1M
Total assets
$14.1B
$122.4M
Long term debt
--
$9.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will PayPal Stock Recover or Keep Sliding?
Payments platform behemoth PayPal Holdings, Inc. (NASDAQ:PYPL) is going through…
How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
49
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 34x
Alerts
Buy
71
PEGA alert for Apr 24
Pegasystems [PEGA] is up 28.8% over the past day.
Buy
67
SMMT alert for Apr 24
Summit Therapeutics [SMMT] is up 21.57% over the past day.
Sell
36
ENPH alert for Apr 24
Enphase Energy [ENPH] is down 15.59% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
